Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
| Purity | ≥70% |
|---|---|
| Formula | C16H14N2O4 |
| Formula Wt. | 298.29 |
| Appearance | Red Powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Endogenous neuropeptide hormone, lowers extrace...
CDK4/6 inhibitor.
Laminin-derived nonapeptide.
Somewhat selective in inhibiting COX-2 over COX...
Recombinant protein containing Treponema pallid...
Mycotoxin produced by Penicillum, Aspergillus, ...
Bisphosphonate, chelating agent.
IGF-1R and InsR inhibitor.
p110α PI3K inhibitor.
Anthraquinone pigment found in madder root; O-a...
Peptide, GLP-1 analog found in Heloderma; GLP-1...
Diterpene found in coffee beans.
Nucleoside (adenosine) analog; DNA chain termin...
Sulforaphane-cysteine conjugate.
CDK4/6 inhibitor.
mTOR inhibitor.
β2-adrenergic agonist.
p110α PI3K inhibitor.
c-MET inhibitor.
Aminoglycoside; protein translation inhibitor, ...